Green Fresh Biotechnology Company Limited (GREEN FRESH BIO) Aktie

Green Fresh Biotechnology Company Limited, an investment holding company, engages in the production of seaweed-based and plant-based hydrocolloid products in the Mainland China, Europe, rest of Asia, South America, North America, Africa, and Oceania. The company operates through five segments: Manufacturing and Sales of Agar-Agar; Manufacturing and Sales of Carrageenan; Manufacturing and Sales of Konjac Products; Manufacturing and Sales of Blended Products; and Others. It offers carrageenan, agar agar, konjac gum, and flour products, as well as blended products; and solutions, including soft candy, jelly/pudding, meat product, plant-based meat product, and other applications. The company was formerly known as Green Future Food Hydrocolloid Marine Science Company Limited and changed its name to Green Fresh Biotechnology Company Limited in July 2025. Green Fresh Biotechnology Company Limited was founded in 2001 and is headquartered in North Point, Hong Kong.